(0.07%) 5 473.38 points
(0.10%) 39 153 points
(0.38%) 17 785 points
(0.14%) $80.94
(-3.66%) $2.66
(-0.77%) $2 312.80
(0.25%) $28.94
(3.64%) $1 022.30
(0.29%) $0.936
(0.67%) $10.67
(0.44%) $0.792
(-0.27%) $87.25
Live Chart Being Loaded With Signals
SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV)...
Stats | |
---|---|
今日成交量 | 49 104 |
平均成交量 | 0 |
市值 | 23.93M |
EPS | $-0.540 ( Q1 | 2024-05-20 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E |
0.120 (Sector) 42.63 (Industry) 24.32 |
ATR14 | $0 (0.00%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-12-07 | Sullivan Eddie Joe | Buy | 1 740 | Common Stock |
2023-11-30 | King Michael | Buy | 5 000 | Common Stock |
2023-11-29 | Reich Samuel J | Buy | 11 000 | Common Stock |
2023-11-24 | Sessa Capital (master), L.p. | Buy | 4 584 571 | Common Stock |
2023-11-24 | Sessa Capital (master), L.p. | Buy | 28 380 | Series A-2 Convertible Preferred Stock |
INSIDER POWER |
---|
67.59 |
Last 48 transactions |
Buy: 15 469 696 | Sell: 3 137 380 |
SAB Biotherapeutics, Inc. 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
SAB Biotherapeutics, Inc. 财务报表
Annual | 2023 |
营收: | $2.24M |
毛利润: | $-1.51M (-67.28 %) |
EPS: | $-7.64 |
FY | 2023 |
营收: | $2.24M |
毛利润: | $-1.51M (-67.28 %) |
EPS: | $-7.64 |
FY | 2022 |
营收: | $23.90M |
毛利润: | $20.61M (86.23 %) |
EPS: | $-4.31 |
FY | 2021 |
营收: | $0.00 |
毛利润: | $0.00 (0.00 %) |
EPS: | $0 |
Financial Reports:
No articles found.
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
Contract Name | Last Trade Date (EDT) | Strike | Last Price | Bid | Ask | Change | % Change | Volume | Open Interest | Implied Volatility | Strike Date |
---|---|---|---|---|---|---|---|---|---|---|---|
No data available |
SAB Biotherapeutics, Inc.
SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV). SAB Biotherapeutics, Inc. was incorporated in 2014 and is based in Sioux Falls, South Dakota with an additional office in Cambridge, Massachusetts.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。